Rehab success rates vary widely depending on how you define “success,” what substance is involved, and how long treatment lasts. The most commonly cited figure is that 40 to 60% of people relapse within the first year after treatment, which means roughly 40 to 60% maintain their recovery over that same period. That puts addiction treatment on par with relapse rates for other chronic conditions like hypertension and asthma. But those numbers shift dramatically based on the type of program, its duration, and whether someone has additional mental health conditions.
How “Success” Is Measured
There’s no single agreed-upon definition of success in addiction treatment, which is part of why the numbers you find online vary so much. Some programs count success as complete abstinence at the 30-day mark. Others look at whether someone is still enrolled in treatment after 12 months. Still others measure broader improvements: fewer days using substances, stable housing, employment, or reduced hospitalizations.
SAMHSA, the federal agency that oversees substance use programs, has acknowledged that simply measuring whether someone used in the past 30 days doesn’t capture the full picture of recovery. A person who went from daily heroin use to a single lapse over six months has made enormous progress, but a strict abstinence measure would count them as a failure. This is worth keeping in mind when you encounter any single success rate number.
Treatment Duration Changes the Odds Significantly
If there’s one factor that consistently predicts outcomes, it’s how long someone stays in treatment. The data here is striking. People who complete fewer than 90 days of treatment relapse at rates of 70 to 80% within the first year. Those who stay 90 days or longer see relapse rates drop to 40 to 60%. And people who remain in some form of treatment for six months or more have first-year relapse rates of only 20 to 30%.
This is why the National Institute on Drug Abuse considers 90 days the minimum effective treatment duration for sustainable recovery. A standard 28- to 30-day residential program produces moderate success rates in the range of 30 to 50%, while programs lasting 90 days or more report success rates between 60 and 90%. The pattern holds regardless of substance type: longer engagement with treatment, whether residential or outpatient, consistently produces better results.
For people with chronic addiction or a history of multiple relapses, six months or more of structured care tends to produce the best long-term outcomes.
Inpatient vs. Outpatient Programs
Inpatient (residential) programs and outpatient programs produce different results depending on what you measure and when. People in inpatient care are about three times more likely to complete their full course of treatment than those in outpatient settings. Inpatients also tend to consume significantly less alcohol in the year after entering treatment and engage more actively with support groups like Alcoholics Anonymous.
That said, the picture isn’t entirely one-sided. Some studies have found that outpatient programs produce comparable or even slightly better short-term abstinence rates at the one- to two-month mark. Inpatient care shows a clear advantage in the percentage of days spent abstinent during the first month after treatment, but that gap typically disappears by the six-month mark. The takeaway is that inpatient care offers a stronger start and higher completion rates, but outpatient programs can be equally effective for people with milder addiction, strong home support, and high motivation.
Medication-Assisted Treatment for Opioid Addiction
For opioid addiction specifically, medication-assisted treatment using drugs that reduce cravings and withdrawal symptoms has become the gold standard. Retention rates after 12 months average around 54%, with methadone-based programs keeping about 57% of participants engaged and buprenorphine-based programs retaining about 48%. These numbers represent people who are still actively in treatment and not using illicit opioids, which is a meaningful measure of success.
Compared to detox-only approaches, where relapse rates are extremely high, medication-assisted treatment roughly doubles the likelihood that someone will still be in recovery a year later. The medications work by occupying the same brain receptors that opioids target, reducing cravings without producing a high. Staying on these medications long-term is not considered a failure. It’s considered effective management of a chronic condition.
Long-Term Recovery After Five Years
The longer someone maintains sobriety, the lower their risk of relapse becomes. A study published in the journal Addiction tracked people over 16 years and found that among those who had achieved three years of remission with professional help, about 57% were still in remission at the 16-year follow-up. For those who achieved early remission without formal treatment, only about 40% maintained it over the same period.
That roughly 15-percentage-point gap between treated and untreated groups held over more than a decade, reinforcing that professional treatment provides lasting protective effects well beyond the initial program. The relapse rate of just over 40% for people who received help is consistent with broader estimates across multiple studies. Getting past the three-year mark appears to be a critical threshold. Once someone reaches it, their odds of sustained recovery improve substantially.
Co-Occurring Mental Health Conditions
About half of people with a substance use disorder also have a co-occurring mental health condition like depression, anxiety, PTSD, or bipolar disorder. This combination, sometimes called dual diagnosis, makes treatment considerably harder. People with dual diagnosis experience more severe symptoms, higher relapse rates, and more frequent hospitalizations compared to those dealing with addiction alone.
The challenge is that untreated depression or anxiety can drive someone back to substance use even after successful detox. Programs that address both conditions simultaneously, through integrated therapy that treats the addiction and the mental health disorder together, produce better outcomes than treating each one separately. If you or someone you know is entering rehab with a known mental health condition, looking for a program specifically designed for dual diagnosis can meaningfully improve the odds.
What Actually Improves Your Odds
Across all the research, a few factors consistently predict better outcomes. Treatment duration is the most powerful: staying engaged for at least 90 days is the single best thing someone can do to reduce their relapse risk. Beyond that, continuing with some form of aftercare, whether that’s outpatient therapy, support groups, or regular check-ins with a counselor, extends the benefits of initial treatment.
Completing the full program matters enormously. People who leave treatment early, even from high-quality programs, relapse at much higher rates than those who finish. Family involvement, stable housing, and employment also contribute to long-term success, though these are harder to control.
It’s also worth reframing what relapse means. Addiction is a chronic, relapsing condition. A single relapse after months of sobriety doesn’t erase the progress made, and it doesn’t mean treatment failed. Many people who eventually achieve long-term recovery experienced one or more relapses along the way. Each treatment episode builds skills and self-awareness that make the next attempt more likely to stick.